Cargando…

Relowering of Serum Na for Osmotic Demyelinating Syndrome

We report a case in whom slow correction of hyponatremia (5 mmol/day for 3 days) induced central pontine myelinolysis (CPM). After the diagnosis was confirmed by imaging, we started to relower serum Na that completely recovered the sign and symptoms of CPM. Rapid correction of serum sodium is known...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Hideomi, Takano, Koji, Ayuzawa, Nobuhiro, Seki, George, Fujita, Toshiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420698/
https://www.ncbi.nlm.nih.gov/pubmed/22937357
http://dx.doi.org/10.1155/2012/704639
_version_ 1782240903412318208
author Yamada, Hideomi
Takano, Koji
Ayuzawa, Nobuhiro
Seki, George
Fujita, Toshiro
author_facet Yamada, Hideomi
Takano, Koji
Ayuzawa, Nobuhiro
Seki, George
Fujita, Toshiro
author_sort Yamada, Hideomi
collection PubMed
description We report a case in whom slow correction of hyponatremia (5 mmol/day for 3 days) induced central pontine myelinolysis (CPM). After the diagnosis was confirmed by imaging, we started to relower serum Na that completely recovered the sign and symptoms of CPM. Rapid correction of serum sodium is known to be associated with CPM. However, it may occur even after slow correction of hyponatremia. Currently, there is no standard therapy for CPM other than supportive therapy. Other therapy includes sterioid, plasmaphresis and IVIG, but these therapies have not been shown to be particularly effective. The pathophysiology of CPM is related to a relative dehydration of the brain during the correction of hyponatremia, resulting in cell death and demyelination, therefore gentle rehydration with lowering serum sodium may not be an unreasonable therapy. The present case provides supportive evidence that reinduction of hyponatremia is effective in treating CPM if started immediately after the diagnosis is suggested. The present case tells us that severe chronic hyponatremia must be managed with extreme care especially in patients with chronic debilitating illness and that relowering serum Na is a treatment of choice when CPM is suggested.
format Online
Article
Text
id pubmed-3420698
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-34206982012-08-30 Relowering of Serum Na for Osmotic Demyelinating Syndrome Yamada, Hideomi Takano, Koji Ayuzawa, Nobuhiro Seki, George Fujita, Toshiro Case Rep Neurol Med Case Report We report a case in whom slow correction of hyponatremia (5 mmol/day for 3 days) induced central pontine myelinolysis (CPM). After the diagnosis was confirmed by imaging, we started to relower serum Na that completely recovered the sign and symptoms of CPM. Rapid correction of serum sodium is known to be associated with CPM. However, it may occur even after slow correction of hyponatremia. Currently, there is no standard therapy for CPM other than supportive therapy. Other therapy includes sterioid, plasmaphresis and IVIG, but these therapies have not been shown to be particularly effective. The pathophysiology of CPM is related to a relative dehydration of the brain during the correction of hyponatremia, resulting in cell death and demyelination, therefore gentle rehydration with lowering serum sodium may not be an unreasonable therapy. The present case provides supportive evidence that reinduction of hyponatremia is effective in treating CPM if started immediately after the diagnosis is suggested. The present case tells us that severe chronic hyponatremia must be managed with extreme care especially in patients with chronic debilitating illness and that relowering serum Na is a treatment of choice when CPM is suggested. Hindawi Publishing Corporation 2012 2012-06-28 /pmc/articles/PMC3420698/ /pubmed/22937357 http://dx.doi.org/10.1155/2012/704639 Text en Copyright © 2012 Hideomi Yamada et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Yamada, Hideomi
Takano, Koji
Ayuzawa, Nobuhiro
Seki, George
Fujita, Toshiro
Relowering of Serum Na for Osmotic Demyelinating Syndrome
title Relowering of Serum Na for Osmotic Demyelinating Syndrome
title_full Relowering of Serum Na for Osmotic Demyelinating Syndrome
title_fullStr Relowering of Serum Na for Osmotic Demyelinating Syndrome
title_full_unstemmed Relowering of Serum Na for Osmotic Demyelinating Syndrome
title_short Relowering of Serum Na for Osmotic Demyelinating Syndrome
title_sort relowering of serum na for osmotic demyelinating syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420698/
https://www.ncbi.nlm.nih.gov/pubmed/22937357
http://dx.doi.org/10.1155/2012/704639
work_keys_str_mv AT yamadahideomi reloweringofserumnaforosmoticdemyelinatingsyndrome
AT takanokoji reloweringofserumnaforosmoticdemyelinatingsyndrome
AT ayuzawanobuhiro reloweringofserumnaforosmoticdemyelinatingsyndrome
AT sekigeorge reloweringofserumnaforosmoticdemyelinatingsyndrome
AT fujitatoshiro reloweringofserumnaforosmoticdemyelinatingsyndrome